Our three new picks this month got off to a bit of a slow start, but they have all recovered very nicely. What’s more, due to the stocks’ price action, most of our readers probably were able to buy shares of these new recommendations at better entry prices than we… Read More
Scott Chan moved from China to the U.S. with family at the age of ten. He passed the rigorous entrance exam and attended the merit-based Stuyvesant High School, widely held to be best public school in New York City. He earned undergraduate degrees from New York University followed by an MBA degree from the Zicklin School of Business at Baruch College.
Shortly thereafter Scott partnered with Dr. Stephen Leeb on numerous financial publications. Today, he serves as the lead analyst for Real World Investing and The Complete Investor.
Mr. Chan is an avid baseball fan and enjoys outdoor activities in his spare time. A multicultural person, he reads Chinese and speaks fluent Mandarin and Cantonese Chinese.
Sell Theravance Biopharma (Nasdaq: TBPH), Franco-Nevada (NYSE: FNV), and USG Corp (NYSE: USG). We recommend taking gains on Theravance Biopharma (Nasdaq: TBPH) and Franco-Nevada (NYSE: FNV), both of which have had nice recent runs. We may revisit these stocks in the future if the opportunity is right. Hurricane Harvey has… Read More
A Chinese online gaming stock has fallen sharply since reporting quarterly results that did not match the previous quarter's blowout numbers. We think the slowdown in mobile-game growth is temporary and the acceleration of growth in its ecommerce business bodes well for a rebound. Read More
We have had good success following Chase Coleman III’s Tiger Global in the past and this week, we again added a top holding from the hedge fund to our portfolio: TAL Education (NYSE: TAL), a leading operator in a booming industry in China: private tutoring. In China, the job market… Read More
Our S&P indicator has continued from its already positive reading. In fact the last time the weekly indicator was as high as today was toward the beginning of 2016, which was a very good time to be in stocks. A further decline in the VIX Index would slightly weaken the… Read More
Buy TAL Education Group (NYSE: TAL) Tiger Global Management owns 9.85 million shares, or about 3.5 percent of the U.S.-traded ADRs of this leading tutorial center operator in China which focuses on high-achieving students in the K to 12 curriculum. A culture that places heavy emphasis on education, the Chinese… Read More
Although Apple (Nasdaq: AAPL) is already, by far, the world's largest company by market cap, it has consistently proven that with one great product, it can still grow. A company trading at a very reasonable valuation, AAPL offers a high floor and we think it is a must-own for investors. Read More
Earlier this week, we added two new high-conviction picks from top money managers. We added ViaSat (Nasdaq: VSAT) from Baupost Group and ChannelAdvisor (NYSE: ECOM) from Shapiro Capital Management. This is the second time we have recommended ViaSat. It was one of our very first recommendations in Brain Trust Profits. Read More
Buy ViaSat, Inc. (Nasdaq: VSAT) and ChannelAdvisor (NYSE: ECOM). Today we are adding to the Brain Trust Profits portfolio two high-conviction picks from two top hedge funds. The first stock ViaSat (Nasdaq: VSAT) should be a familiar name to long-time subscribers. We found the stock in Seth Klarman’s Baupost Group… Read More
After a heated run beyond the $40 mark, this biotech stock has taken a hard fall over the past 7 weeks. Yet nothing significant has happened to its intriguing pipeline. The share price and expectation have reset and it's time to consider buying some shares. Read More